Yerly S - Search Results

1

Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection.

Metzner KJ, Scherrer AU, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Böni J, Yerly S, Klimkait T, Aubert V, Furrer H, Battegay M, Vernazza PL, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard HF; Swiss HIV Cohort Study. Metzner KJ, et al. Among authors: yerly s. J Infect Dis. 2013 Oct 1;208(7):1102-12. doi: 10.1093/infdis/jit310. Epub 2013 Jul 11. J Infect Dis. 2013. PMID: 23847055 Free article.

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.

Yerly S, Chamot E, Déglon JJ, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1991 Nov;164(5):965-8. doi: 10.1093/infdis/164.5.965. J Infect Dis. 1991. PMID: 1940476

4

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

5

V3 sequences in primary HIV-1 infection.

Antonioli IM, Baumberger C, Yerly S, Perrin L. Antonioli IM, et al. Among authors: yerly s. AIDS. 1995 Jan;9(1):11-7. doi: 10.1097/00002030-199501000-00002. AIDS. 1995. PMID: 7893436

6

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. Among authors: yerly s. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

7

[Prevalence of transmission of zidovudine-resistant viruses in Switzerland. l'Etude suisse de cohorte VIH].

Yerly S, Rakik A, Kinloch-de-Loes S, Erb P, Vernazza P, Hirschel B, Perrin L. Yerly S, et al. Schweiz Med Wochenschr. 1996 Oct 26;126(43):1845-8. Schweiz Med Wochenschr. 1996. PMID: 9005525 French.

8

A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.

Yerly S, Perneger TV, Hirschel B, Dubuis O, Matter L, Malinverni R, Furrer H, Perrin L. Yerly S, et al. Arch Intern Med. 1998 Feb 9;158(3):247-52. doi: 10.1001/archinte.158.3.247. Arch Intern Med. 1998. PMID: 9472204

9

Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.

Yerly S, Rakik A, De Loes SK, Hirschel B, Descamps D, Brun-Vézinet F, Perrin L. Yerly S, et al. J Virol. 1998 May;72(5):3520-3. doi: 10.1128/JVI.72.5.3520-3523.1998. J Virol. 1998. PMID: 9557630 Free PMC article.

10

Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy.

Perrin L, Yerly S, Marchal F, Schockmel GA, Hirschel B, Fox CH, Pantaleo G. Perrin L, et al. Among authors: yerly s. J Infect Dis. 1998 Jun;177(6):1497-501. doi: 10.1086/515303. J Infect Dis. 1998. PMID: 9607825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

510 results

Search Page